Skadden, Arps, Slate, Meagher & Flom advised BridgeBio Pharma Inc. in connection with a transaction agreement providing for the formation and funding by certain third party investors of GondolaBio LLC as a joint venture for the purpose of researching, developing, manufacturing and commercializing pharmaceutical products, including those contributed to GondolaBio by BridgeBio. Goodwin Procter and Richards, Layton & Finger counseled BridgeBio's special committee. Counsel information was not immediately available for GondolaBio.
Biotech & Pharmaceuticals
August 22, 2024, 6:10 PM